Cargando…

Identification of Potential Drug Targets in Helicobacter pylori Using In Silico Subtractive Proteomics Approaches and Their Possible Inhibition through Drug Repurposing

The class 1 carcinogen, Helicobacter pylori, is one of the World Health Organization’s high priority pathogens for antimicrobial development. We used three subtractive proteomics approaches using protein pools retrieved from: chokepoint reactions in the BIOCYC database, the Kyoto Encyclopedia of Gen...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ibrahim, Kareem A., Helmy, Omneya M., Kashef, Mona T., Elkhamissy, Tharwat R., Ramadan, Mohammed A.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2020
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7558524/ https://www.ncbi.nlm.nih.gov/pubmed/32932580 http://dx.doi.org/10.3390/pathogens9090747

Ejemplares similares

Aspartate α-decarboxylase a new therapeutic target in the fight against Helicobacter pylori infection
por: Ibrahim, Kareem A., et al.
Publicado: (2022)

Repurposing the anthelmintic drug niclosamide to combat Helicobacter pylori
por: Tharmalingam, Nagendran, et al.
Publicado: (2018)

In Silico Subtractive Proteomics Approach for Identification of Potential Drug Targets in Staphylococcus saprophyticus
por: Shahid, Farah, et al.
Publicado: (2020)

Different phenotypic and molecular mechanisms associated with multidrug resistance in Gram-negative clinical isolates from Egypt
por: Helmy, Omneya M, et al.
Publicado: (2017)

Development of a Multiplex Polymerase Chain Reaction-Based DNA Lateral Flow Assay as a Point-of-Care Diagnostic for Fast and Simultaneous Detection of MRSA and Vancomycin Resistance in Bacteremia
por: Kashef, Mona T., et al.
Publicado: (2022)

Repurposing Dihydropyridines for Treatment of Helicobacter pylori Infection
por: González, Andrés, et al.
Publicado: (2019)

On the Integration of In Silico Drug Design Methods for Drug Repurposing
por: March-Vila, Eric, et al.
Publicado: (2017)

Integrative approach for the analysis of the proteome-wide response to bismuth drugs in Helicobacter pylori
por: Wang, Yuchuan, et al.
Publicado: (2017)

In silico repurposing of antipsychotic drugs for Alzheimer’s disease
por: Kumar, Shivani, et al.
Publicado: (2017)

In Silico Repurposed Drugs against Monkeypox Virus
por: Lam, Hilbert Yuen In, et al.
Publicado: (2022)

The Possible Role of Helicobacter pylori in Gastric Cancer and Its Management
por: Alfarouk, Khalid O., et al.
Publicado: (2019)

Subtractive proteomics analysis to uncover the potent drug targets for distinctive drug design of Candidaauris
por: Bappy, Md. Nazmul Islam, et al.
Publicado: (2023)

A Systematic In-silico Analysis of Helicobacter pylori Pathogenic Islands for Identification of Novel Drug Target Candidates
por: Nammi, Deepthi, et al.
Publicado: (2017)

Drug Repurposing Based on Protozoan Proteome: In Vitro Evaluation of In Silico Screened Compounds against Toxoplasma gondii
por: Cajazeiro, Débora Chaves, et al.
Publicado: (2022)

Identification of repurposable drug targets in Mycoplasma pneumoniae using subtractive genomics, molecular docking and dynamics simulation
por: Chowdhury, Zeshan Mahmud, et al.
Publicado: (2023)

Breastfeeding and Helicobacter Pylori Infection in Children with Digestive Symptoms
por: Monajemzadeh, Maryam, et al.
Publicado: (2010)

Proteomics advances towards developing SARS-CoV-2 therapeutics using in silico drug repurposing approaches
por: Mukherjee, Amrita, et al.
Publicado: (2021)

Proteomics and Drug Repurposing in CLL towards Precision Medicine
por: Mavridou, Dimitra, et al.
Publicado: (2021)

Potentially Infectious Helicobacter pylori in Tap Water in Kermanshah, Western Iran
por: Hasanvand, Banafsheh, et al.
Publicado: (2023)

Repurposing of existing FDA approved drugs for Neprilysin inhibition: An in-silico study
por: Sankhe, Runali, et al.
Publicado: (2021)

In silico studies on therapeutic agents for COVID-19: Drug repurposing approach
por: Shah, Bhumi, et al.
Publicado: (2020)

In silico drug repurposing in COVID-19: A network-based analysis
por: Sibilio, Pasquale, et al.
Publicado: (2021)

Drug repurposing approach against chikungunya virus: an in vitro and in silico study
por: Kasabe, Bhagyashri, et al.
Publicado: (2023)

Potential of FTIR-Spectroscopy for Drugs Screening against Helicobacter pylori
por: Sampaio, Pedro Sousa, et al.
Publicado: (2020)

Drug-Resistant Helicobacter pylori: Diagnosis and Evidence-Based Approach
por: Jearth, Vaneet, et al.
Publicado: (2023)

Potential Antigenic Candidates for the Development of Peptide-Based Vaccines to Induce Immunization against Helicobacter pylori Infection in BALB/c Mice
por: AlEraky, Doaa M., et al.
Publicado: (2022)

In-Silico targeting of SARS-CoV-2 NSP6 for drug and natural products repurposing
por: Abdelkader, Ahmed, et al.
Publicado: (2022)

In Silico and In Vitro Potential of FDA-Approved Drugs for Antimalarial Drug Repurposing against Plasmodium Serine Hydroxymethyltransferases
por: Mee-udorn, Pitchayathida, et al.
Publicado: (2023)

Metabolic modelling-based in silico drug target prediction identifies six novel repurposable drugs for melanoma
por: Bintener, Tamara, et al.
Publicado: (2023)

Network-based approach to prediction and population-based validation of in silico drug repurposing
por: Cheng, Feixiong, et al.
Publicado: (2018)

A genome-wide positioning systems network algorithm for in silico drug repurposing
por: Cheng, Feixiong, et al.
Publicado: (2019)

Computational drug repurposing in the age of COVID-19: mixing antiviral cocktails in silico
por: Diao, James A., et al.
Publicado: (2022)

Preliminary In Vitro and In Vivo Insights of In Silico Candidate Repurposed Drugs for Alzheimer’s Disease
por: Savva, Kyriaki, et al.
Publicado: (2023)

Corrigendum: Drug repurposing approach against chikungunya virus: an in vitro and in silico study
por: Kasabe, Bhagyashri, et al.
Publicado: (2023)

In Silico Drug Repurposing in Multiple Sclerosis Using scRNA-Seq Data
por: Shevtsov, Andrey, et al.
Publicado: (2023)

In Silico and In Vitro Anti-Helicobacter Pylori Effects of Combinations of Phytochemicals and Antibiotics
por: Fong, Pedro, et al.
Publicado: (2019)

Albendazole repurposing on VEGFR-2 for possible anticancer application: In-silico analysis
por: Gaikwad, Nikita Maruti, et al.
Publicado: (2023)

The proteomics analysis of extracellular vesicles revealed the possible function of heat shock protein 60 in Helicobacter pylori infection
por: Li, Yujie, et al.
Publicado: (2023)

Evaluation of Helicobacter pylori eradication and drug therapy in patients with functional dyspepsia
por: ZHAO, WEIDONG, et al.
Publicado: (2013)

Successful Suppression of Drug-Resistant Helicobacter pylori Infection With Bismuth Subsalicylate
por: Geng, Calvin, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_rachmuv2mr7fhh8nrrc00u15r4